If Republican nominees Melissa Holyoak of Utah and Andrew Ferguson of Virginia are confirmed, as expected, to join the Federal Trade Commission this month, they could change the dynamics of an agency that’s been under single-party control for half...
Hard cases are notorious for making bad law. But sometimes the easy and obvious cases can make bad law, too. Something like this seems to be going on with insulin pricing.
Current Issue: 926
After big data breaches the congressional reaction is almost always the same: hold a hearing, chastise a current or former chief executive, and fail to pass a bill to deal with the broader problem.
The day before Makan Delrahim was confirmed to head the Justice Department’s antitrust division, the government made news by challenging Parker-Hannifin’s acquisition of Clarcor, a $4.3 billion deal.
When the Federal Trade Commission and New York’s attorney general joined forces to sue Quincy Bioscience for deceptive advertising in promoting Prevagen, a dietary supplement, the enforcers came...
One of President Donald Trump’s campaign promises was to bring down drug prices, often blasting pharmaceutical companies for “getting away with murder.”
US companies are still waiting to find out if the European Commission will continue the trans-Atlantic data transmission agreement called the EU-US Privacy Shield after regulators on both sides of...
In an era of global finance and global financial crime, US antitrust prosecutors have turned their sights on targets worldwide, bringing recent cases against bankers in London, Paris and...